Evaluation of Intra-Abdominal Fat Extraction Using HydraSolve T2D™ in Obese Subjects With Type 2 Diabetes

Inclusion Criteria: * 1\. Willingness to provide written informed consent. 2\. Willingness and availability to comply with study requirements for the duration of the study, including specific inquiry that the potential subject does not have an impending move or travel planned and can attend the patient visits without undue hardship. 3\. Male or female between 22 - 75 years of age. (Caveat: premenopausal women are excluded) 4\. In good general health except for being diagnosed as having T2D,and in good enough general health to undergo a conversion from a mini-laparotomy to an open laparotomy incision if that conversion becomes necessary during the operative procedure; the subject has no major system disease other than T2D as determined by physical examination, medical history, screening laboratory tests, and EKG. 5\. BMI 30 to 39.9 kg/m2. 6\. Stable body weight during the 6 month time period preceding the anticipated surgery date. (Stable is defined as: the usual baseline body weight of the subject +/- \< 5% change.) 7\. Diagnosis of T2D 10 years or less in duration. 8\. Subject has poorly controlled T2D and is on a current regimen of at least two oral hypoglycemic agents, the first medication dosed at the maximum dose, and the second dosed at the minimum or higher labelled dose. Subject's treatment regime does not include insulin treatment. 9\. HbA1c: 8.0 % - 10.0 %, taken within 30 days pre-op. 10\. Subjects receiving exogenous thyroid hormone, a …